View Older Stories View More Recent Stories
-
Hercules Capital Prices Public Offering of $40 Million 6.25% Notes due 2033
-
INSYS Therapeutics to Present at Janney Healthcare Conference
-
Janney Remains Bullish on Global Blood Therapeutics (GBT) Voxelotor
-
Champions Oncology to Participate at the Janney Montgomery Scott Healthcare Conference 2018 in New York
-
Janney Montgomery Scott Starts Concert Pharmaceuticals (CNCE) at Neutral
-
Janney Montgomery Scott Starts Aldeyra Therapeutics (ALDX) at Buy
-
Monroe Capital Corporation Announces Closing of Public Offering of $69 Million 5.75% Notes Due 2023
-
Monroe Capital Corporation Announces Closing of Public Offering of $69 Million 5.75% Notes Due 2023
-
TapImmune To Present at 2018 Janney Healthcare Conference
-
B. Riley Financial Announces Closing of Senior Notes Offering
-
No News to Explain Agile Therapeutics' (AGRX) Wild Move - Janney
-
Provention Bio To Present at 2018 Janney Healthcare Conference
-
OncoCyte Corp (OCX) PT Doubled to $4 at Janney Montgomery Scott
-
Janney Remains Neutral on Acorda Therapeutics (ACOR)
-
BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference
-
BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference
-
UPDATE: Janney Upgrades SJW Group (SJW) to Buy
-
B. Riley Financial Announces Pricing of Senior Notes Offering
-
B. Riley Financial Announces Offering of $50 Million Senior Notes Due 2023 and Receipt of Investment Grade Rating of “A-” from Egan-Jones
-
Monroe Capital Corporation Prices Public Offering of $60 Million 5.75% Notes Due 2023
-
Monroe Capital Corporation Prices Public Offering of $60 Million 5.75% Notes Due 2023
-
Monroe Capital Corporation Announces Public Offering of Notes and A- Rating from Egan-Jones Ratings Company
-
Monroe Capital Corporation Announces Public Offering of Notes and A- Rating from Egan-Jones Ratings Company
-
KemPharm to Present at Two Healthcare Investor Conferences During September 2018
-
Sarepta Therapeutics to Present at Two Upcoming Investor Conferences
-
ContraFect to Present at Two Upcoming Investor Conferences
-
Janney Montgomery Scott Downgrades Assertio Therapeutics (ASRT) to Neutral
-
Avid Bioservices to Present at Upcoming Investor Conferences
-
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
-
Janney Montgomery Scott Downgrades Realty Income (O) to Neutral
-
Janney Montgomery Scott Downgrades Capital Product (CPLP) to Neutral
-
West Announces Participation in Upcoming September Investor Conferences
-
Gladstone Investment Corporation Announces Closing of Offering of 2,990,000 Shares of its 6.375% Series E Cumulative Term Preferred Stock for Gross Proceeds of Approximately $74.8 million
-
Gladstone Investment Corporation Announces Closing of Offering of 2,990,000 Shares of its 6.375% Series E Cumulative Term Preferred Stock for Gross Proceeds of Approximately $74.8 million
-
Janney Starts Nightstar Therapeutics (NITE) at Buy
-
Saratoga Investment Corp. Prices Public Offering of $35 Million 6.25% Notes Due 2025
-
Saratoga Investment Corp. Prices Public Offering of $35 Million 6.25% Notes Due 2025
-
Saratoga Investment Corp. Announces Offering of Notes Due 2025 and BBB Investment Grade Rating from Egan-Jones Ratings Company.
-
Saratoga Investment Corp. Announces Offering of Notes Due 2025 and BBB Investment Grade Rating from Egan-Jones Ratings Company.
-
Instant View: Trump takes Fed to task for rate hikes in Reuters interview
-
Exclusive: Trump demands Fed help on economy, complains about interest rate rises
-
Janney Montgomery Scott Upgrades America's Car-Mart (CRMT) to Buy
-
Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences
-
Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences
-
Janney Starts Azure Power Global Limited (AZRE) at Buy
-
Gladstone Investment Corporation Prices Series E Term Preferred Stock Offering
-
Gladstone Investment Corporation Prices Series E Term Preferred Stock Offering
-
Gladstone Investment Corporation Launches New Series E Term Preferred Stock Offering
-
Gladstone Investment Corporation Launches New Series E Term Preferred Stock Offering
-
Middlesex Water (MSEX) PT Raised to $47 at Janney Following Model Update

